Harnessing T-Cell Immunity to Target Brain Tumors

por Walker, Paul R., Prins, Robert M., Dietrich, Pierre-Yves, Liau, Linda M.
Publicado 2008

IMMU-30. UPREGULATED T CELL AND INTERFERON-Γ-RELATED GENE EXPRESSION IS ASSOCIATED WITH INCREASED SURVIVAL IN RECURRENT PEDIATRIC HIGH-GRADE GLIOMA

por Davidson, Tom, Hugo, Willy, Wang, Anthony, Kim, Jiyoon, Li, Gang, Prins, Robert
Publicado 2020

The histone deacetylase inhibitor, LBH589, promotes the systemic cytokine and effector responses of adoptively transferred CD8+ T cells

por Lisiero, Dominique N, Soto, Horacio, Everson, Richard G, Liau, Linda M, Prins, Robert M
Publicado 2014

Adjuvant inhibition of iAPC function in the tumor microenvironment promotes therapeutic immunity in the setting of vaccination-induced T cell anti-tumor response

por Antonios, Joseph, Soto, Horacio, Orpilla, Joey, Shin, Namjo, Everson, Richard, Liau, Linda, Prins, Robert
Publicado 2015

Estimating radiation effective doses from whole body computed tomography scans based on U.S. soldier patient height and weight

por Prins, Robert D, Thornton, Raymond H, Schmidtlein, C Ross, Quinn, Brian, Ching, Hung, Dauer, Lawrence T
Publicado 2011

DDRE-23. A COMPREHENSIVE CHARACTERIZATION OF THE GBM LIPIDOME REVEALS A MOLECULARLY-DEFINED SUB-GROUP WITH HEIGHTENED SENSITIVITY TO LIPID PEROXIDATION INDUCED CELL DEATH

por Morrow, Danielle, Minami, Jenna, Bayley, Nicholas, Williams, Kevin, Bensinger, Steven, Prins, Robert, Liau, Linda, Cloughesy, Timothy, Nathanson, David
Publicado 2021

Cellular and vaccine therapeutic approaches for gliomas

por Hickey, Michelle J, Malone, Colin C, Erickson, Kate L, Jadus, Martin R, Prins, Robert M, Liau, Linda M, Kruse, Carol A
Publicado 2010

Monitoring of Regulatory T Cell Frequencies and Expression of CTLA-4 on T Cells, before and after DC Vaccination, Can Predict Survival in GBM Patients

por Fong, Brendan, Jin, Richard, Wang, Xiaoyan, Safaee, Michael, Lisiero, Dominique N., Yang, Isaac, Li, Gang, Liau, Linda M., Prins, Robert M.
Publicado 2012

Correction: Monitoring of Regulatory T Cell Frequencies and Expression of CTLA-4 on T Cells, before and after DC Vaccination, Can Predict Survival in GBM Patients

por Fong, Brendan, Jin, Richard, Wang, Xiaoyan, Safaee, Michael, Lisiero, Dominique N., Yang, Isaac, Li, Gang, Liau, Linda M., Prins, Robert M.
Publicado 2012

Correction: Monitoring of Regulatory T Cell Frequencies and Expression of CTLA-4 on T Cells, before and after DC Vaccination, Can Predict Survival in GBM Patients

por Fong, Brendan, Jin, Richard, Wang, Xiaoyan, Safaee, Michael, Lisiero, Dominique N., Yang, Isaac, Li, Gang, Liau, Linda M., Prins, Robert M.
Publicado 2012

IMMU-04. TARGETING ALTERNATIVE SPLICING VARIANTS TO STIMULATE ANTI-TUMOR IMMUNITY IN A NOVEL SYNGENEIC MOUSE MODEL OF DIFFUSE HEMISPHERIC GLIOMA, H3 G34-MUTANT

por Owens, Geoffrey, Pan, Yang, Treger, Janet, Contreras, Erick, Soto, Horacio, Armellini, Amber, Na, Brian, Liau, Linda, Prins, Robert, Xing, Yi, Wang, Anthony
Publicado 2023

Antigen presentation by clonally diverse CXCR5+ B cells to CD4 and CD8 T cells is associated with durable response to immune checkpoint inhibitors

por Ding, Lizhong, Sun, Lu, Bu, Melissa T., Zhang, Yanjun, Scott, Lauren N., Prins, Robert M., Su, Maureen A., Lechner, Melissa G., Hugo, Willy
Publicado 2023

Quantitative PET reporter gene imaging of CD8(+) T cells specific for a melanoma-expressed self-antigen

por Shu, Chengyi J., Radu, Caius G., Shelly, Stephanie M., Vo, Dan D., Prins, Robert, Ribas, Antoni, Phelps, Michael E., Witte, Owen N.
Publicado 2009

Decitabine immunosensitizes human gliomas to NY-ESO-1 specific T lymphocyte targeting through the Fas/Fas Ligand pathway

por Konkankit, Veerauo V, Kim, Won, Koya, Richard C, Eskin, Ascia, Dam, Mai-Anh, Nelson, Stanley, Ribas, Antoni, Liau, Linda M, Prins, Robert M
Publicado 2011

Cytokine responsiveness of CD8(+) T cells is a reproducible biomarker for the clinical efficacy of dendritic cell vaccination in glioblastoma patients

por Everson, Richard G, Jin, Richard M, Wang, Xiaoyan, Safaee, Michael, Scharnweber, Rudi, Lisiero, Dominique N, Soto, Horacio, Liau, Linda M, Prins, Robert M
Publicado 2014

Activated autologous dendritic cells injected intratumorally are able to overcome local and systemic immune suppression imposed by the tumor and its microenvironment

por Subbiah, Vivek, Kayaleh, Omar, Murthy, Ravi, Hong, David, Fu, Siqing, Naing, Aung, Conley, Anthony, Hosing, Chitra, Kaur, Indreshpal, Prins, Robert, Meric-Bernstam, Funda, Bosch, Marnix
Publicado 2014

Evidence for Innate and Adaptive Immune Responses in a Cohort of Intractable Pediatric Epilepsy Surgery Patients

por Owens, Geoffrey C., Garcia, Alejandro J., Mochizuki, Aaron Y., Chang, Julia W., Reyes, Samuel D., Salamon, Noriko, Prins, Robert M., Mathern, Gary W., Fallah, Aria
Publicado 2019

Precision Medicine in Pediatric Neurooncology: A Review

por Mochizuki, Aaron Y., Frost, Isaura M., Mastrodimos, Melina B., Plant, Ashley S., Wang, Anthony C., Moore, Theodore B., Prins, Robert M., Weiss, Paul S., Jonas, Steven J.
Publicado 2017

The future of cancer immunotherapy for brain tumors: a collaborative workshop

por Brown, Christine E., Bucktrout, Samantha, Butterfield, Lisa H., Futer, Olga, Galanis, Evanthia, Hormigo, Adilia, Lim, Michael, Okada, Hideho, Prins, Robert, Marr, Sara Siebel, Tanner, Kirk
Publicado 2022

Safety, feasibility and functionality of activated autologous dendritic cells for intratumoral injection in solid tumors: a Phase I clinical trial

por Subbiah, Vivek, Murthy, Ravi, Hong, David, Prins, Robert, Hosing, Chitra, Brown, Robert, Mary, McGuire, Naing, Aung, Fu, Siquing, Conley, Anthony, Kaur, Indreshpaul, Hendricks, Kyle, Kolli, Deepthi, Noffsinger, Lori, Bosch, Marnix
Publicado 2015